Correlation Between Coloplast and Genmab AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Coloplast and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coloplast and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coloplast AS and Genmab AS, you can compare the effects of market volatilities on Coloplast and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coloplast with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coloplast and Genmab AS.

Diversification Opportunities for Coloplast and Genmab AS

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Coloplast and Genmab is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Coloplast AS and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and Coloplast is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coloplast AS are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of Coloplast i.e., Coloplast and Genmab AS go up and down completely randomly.

Pair Corralation between Coloplast and Genmab AS

Assuming the 90 days trading horizon Coloplast AS is expected to generate 0.97 times more return on investment than Genmab AS. However, Coloplast AS is 1.03 times less risky than Genmab AS. It trades about -0.02 of its potential returns per unit of risk. Genmab AS is currently generating about -0.18 per unit of risk. If you would invest  92,200  in Coloplast AS on September 4, 2024 and sell it today you would lose (2,320) from holding Coloplast AS or give up 2.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Coloplast AS  vs.  Genmab AS

 Performance 
       Timeline  
Coloplast AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Coloplast AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Coloplast is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Coloplast and Genmab AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Coloplast and Genmab AS

The main advantage of trading using opposite Coloplast and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coloplast position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.
The idea behind Coloplast AS and Genmab AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Money Managers
Screen money managers from public funds and ETFs managed around the world